角膜上皮
再生(生物学)
角膜
纤溶酶原激活剂
伤口愈合
上皮
细胞生物学
细胞外基质
生物
尿激酶
基质金属蛋白酶
细胞迁移
病理
免疫学
细胞
内分泌学
医学
神经科学
生物化学
遗传学
作者
Koji Sugioka,Teruo Nishida,Aya Kodama-Takahashi,Junko Murakami,Masahiko Fukuda,Osamu Matsuo,Shunji Kusaka
标识
DOI:10.1016/j.exer.2023.109559
摘要
Urokinase-type plasminogen activator (uPA) is a serine protease that plays a central role in the pericellular fibrinolytic system, mediates the degradation of extracellular matrix proteins and activation of growth factors, and contributes to the regulation of various cellular processes including cell migration and adhesion, chemotaxis, and angiogenesis. The corneal epithelium responds rapidly to injury by initiating a wound healing process that involves cell migration, cell proliferation, and tissue remodeling. It is innervated by sensory nerve endings that play an important role in the maintenance of corneal epithelial homeostasis and in the wound healing response. We here investigated the role of uPA in corneal nerve regeneration and epithelial resurfacing after corneal injury with the use of uPA-deficient mice. Both the structure of the corneal epithelium and the pattern of corneal innervation in uPA−/− mice appeared indistinguishable from those in uPA+/+ mice. Whereas the cornea was completely resurfaced by 36–48 h after epithelial scraping in uPA+/+ mice, however, such resurfacing required at least 72 h in uPA−/− mice. Restoration of epithelial stratification was also impaired in the mutant mice. Fibrin zymography revealed that the expression of uPA increased after corneal epithelial scraping and returned to basal levels in association with completion of re-epithelialization in wild-type animals. Staining of corneal whole-mount preparations for βIII-tubulin also revealed that the regeneration of corneal nerves after injury was markedly delayed in uPA−/− mice compared with uPA+/+ mice. Our results thus demonstrate an important role for uPA in both corneal nerve regeneration and epithelial migration after epithelial debridement, and they may provide a basis for the development of new treatments for neurotrophic keratopathy.
科研通智能强力驱动
Strongly Powered by AbleSci AI